Director, Global Commercial Strategy – GI
Johnson & Johnson
June 29, 2026
Remote friendly (Spring House, PA)
United States
Marketing
Director, Global Commercial Strategy – GI (Horsham, PA or Spring House, PA)
Purpose
- Drive integrated commercial strategy across early discovery through late-stage GI development assets. Partner with GCSO, R&D, Medical Affairs, Market Access, Business Development, and regional teams to embed commercial input early, shape development decisions, advance launch readiness, and maximize long-term asset/portfolio value.
Key Responsibilities
Early Development & Portfolio Strategy
- Serve as commercial lead for early-stage Compound Development Teams; embed commercial strategy from discovery through proof-of-concept.
- Translate DAS roadmap into asset-level strategies (disease spaces, patient segments, value drivers, differentiation, evidence needs).
- Shape TPPs, indication sequencing, competitive positioning, and go/no-go criteria.
- Provide input into clinical trial design (endpoints, comparator, patient enrichment, line-of-therapy, label-enabling evidence).
- Drive portfolio prioritization and evaluate external assets/combination/white-space opportunities.
- Develop executive-ready recommendations for governance forums.
Late Development & Launch Preparation
- Translate asset strategy into launch-ready commercial plans (indication prioritization, evidence gaps, positioning, value proposition).
- Lead late-stage commercial workstreams with forecasting from regional input.
- Shape pre-launch planning (TPP refinement, launch sequencing, brand positioning, evidence, stakeholder engagement).
- Pressure-test launch assumptions; develop recommendations for governance/investment decisions.
Qualifications
- Bachelor’s degree required; advanced degree preferred (MBA, PharmD, PhD, MD, or related).
- 10+ years progressive experience in commercial strategy/marketing/business development/market access/medical affairs/R&D strategy or related.
- Demonstrated commercial strategy experience across pipeline/early/late-stage/launch assets (ideally immunology, gastroenterology, or specialty medicine).
- Strong understanding of drug development, clinical trial design/endpoints, regulatory considerations, evidence generation, market access, and global commercialization.
- Excellent written/verbal communication; executive-ready narratives.
Preferred
- Ability to shape TPPs, value propositions, positioning, and investment recommendations.
- Experience leading complex global cross-functional initiatives in a matrix environment; influence senior stakeholders without direct authority.
Other
- Up to 10% domestic and international travel.
Purpose
- Drive integrated commercial strategy across early discovery through late-stage GI development assets. Partner with GCSO, R&D, Medical Affairs, Market Access, Business Development, and regional teams to embed commercial input early, shape development decisions, advance launch readiness, and maximize long-term asset/portfolio value.
Key Responsibilities
Early Development & Portfolio Strategy
- Serve as commercial lead for early-stage Compound Development Teams; embed commercial strategy from discovery through proof-of-concept.
- Translate DAS roadmap into asset-level strategies (disease spaces, patient segments, value drivers, differentiation, evidence needs).
- Shape TPPs, indication sequencing, competitive positioning, and go/no-go criteria.
- Provide input into clinical trial design (endpoints, comparator, patient enrichment, line-of-therapy, label-enabling evidence).
- Drive portfolio prioritization and evaluate external assets/combination/white-space opportunities.
- Develop executive-ready recommendations for governance forums.
Late Development & Launch Preparation
- Translate asset strategy into launch-ready commercial plans (indication prioritization, evidence gaps, positioning, value proposition).
- Lead late-stage commercial workstreams with forecasting from regional input.
- Shape pre-launch planning (TPP refinement, launch sequencing, brand positioning, evidence, stakeholder engagement).
- Pressure-test launch assumptions; develop recommendations for governance/investment decisions.
Qualifications
- Bachelor’s degree required; advanced degree preferred (MBA, PharmD, PhD, MD, or related).
- 10+ years progressive experience in commercial strategy/marketing/business development/market access/medical affairs/R&D strategy or related.
- Demonstrated commercial strategy experience across pipeline/early/late-stage/launch assets (ideally immunology, gastroenterology, or specialty medicine).
- Strong understanding of drug development, clinical trial design/endpoints, regulatory considerations, evidence generation, market access, and global commercialization.
- Excellent written/verbal communication; executive-ready narratives.
Preferred
- Ability to shape TPPs, value propositions, positioning, and investment recommendations.
- Experience leading complex global cross-functional initiatives in a matrix environment; influence senior stakeholders without direct authority.
Other
- Up to 10% domestic and international travel.